Cefadroxil and cephalexin pharmacokinetics and pharmacodynamics in children with musculoskeletal infections.

cefadroxil cephalexin osteomyelitis pediatric drug therapy pediatric infectious disease pharmacodynamics pharmacokinetics

Journal

Antimicrobial agents and chemotherapy
ISSN: 1098-6596
Titre abrégé: Antimicrob Agents Chemother
Pays: United States
ID NLM: 0315061

Informations de publication

Date de publication:
10 Apr 2024
Historique:
medline: 10 4 2024
pubmed: 10 4 2024
entrez: 10 4 2024
Statut: aheadofprint

Résumé

Cephalexin, a first-generation cephalosporin, is the first-line oral therapy for children with musculoskeletal infections due to methicillin-susceptible

Identifiants

pubmed: 38597672
doi: 10.1128/aac.00182-24
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0018224

Auteurs

Andrew S Haynes (AS)

Children's Hospital Colorado, Department of Pediatrics, Section of Pediatric Infectious Diseases, Aurora, Colorado, USA.
University of Colorado Anschutz Medical Campus, School of Medicine, Aurora, Colorado, USA.

Zixuan Wei (Z)

University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, Colorado, USA.

Peter Anderson (P)

University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, Colorado, USA.

Marc H Scheetz (MH)

Midwestern University, Pharmacometrics Center of Excellence, Colleges of Pharmacy and Pharmacology, Downers Grove, Illinois, USA.

Sarah K Parker (SK)

Children's Hospital Colorado, Department of Pediatrics, Section of Pediatric Infectious Diseases, Aurora, Colorado, USA.
University of Colorado Anschutz Medical Campus, School of Medicine, Aurora, Colorado, USA.

Douglas N Fish (DN)

University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, Colorado, USA.

Classifications MeSH